Article
[Current status of castration resistant prostate cancer basic research].
Nihon rinsho. Japanese journal of clinical medicine - 1 Dec 2014
Sakamoto Shinichi, Ichikawa Tomohiko
Abstract excerpt
Recently, novel anti-androgen and CYP-17 inhibitor have been introduced in clinical practice and significance of androgen mediated pathway is re-acknowledged in basic research of castration resistant prostate cancer (CRPC). Generations of AR splicing variant and/or AR mutation, which result in li...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
